{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:01:44Z","timestamp":1762898504563},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T00:00:00Z","timestamp":1252972800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/sj.bjc.6605325","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T20:01:12Z","timestamp":1253044872000},"page":"1091-1099","source":"Crossref","is-referenced-by-count":24,"title":["Bladder cancer in cancer patients: population-based estimates from a large Swedish study"],"prefix":"10.1038","volume":"101","author":[{"given":"J Lorenzo","family":"Bermejo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,15]]},"reference":[{"key":"BF6605325_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000108942","volume":"65","author":"AS Andrew","year":"2008","unstructured":"Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P, Matullo G (2008) DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered 65: 105\u2013118","journal-title":"Hum Hered"},{"issue":"9","key":"BF6605325_CR2","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1002\/ijc.24178","volume":"124","author":"JL Bermejo","year":"2008","unstructured":"Bermejo JL, Sundquist J, Hemminki K (2008) Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden. Int J Cancer 124 (9): 2166\u20132171","journal-title":"Int J Cancer"},{"key":"BF6605325_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ijc.2910620108","volume":"62","author":"T Bjorge","year":"1995","unstructured":"Bjorge T, Hennig EM, Skare GB, Soreide O, Thoresen SO (1995) Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970\u20131992. Int J Cancer 62: 29\u201333","journal-title":"Int J Cancer"},{"key":"BF6605325_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1200\/JCO.1995.13.1.283","volume":"13","author":"C Bokemeyer","year":"1995","unstructured":"Bokemeyer C, Schmoll HJ (1995) Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 13: 283\u2013292","journal-title":"J Clin Oncol"},{"key":"BF6605325_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.eururo.2007.07.002","volume":"52","author":"PJ Bostrom","year":"2007","unstructured":"Bostrom PJ, Soloway MS (2007) Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? Eur Urol 52: 973\u2013982","journal-title":"Eur Urol"},{"key":"BF6605325_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.juro.2007.08.157","volume":"179","author":"PJ Bostrom","year":"2008","unstructured":"Bostrom PJ, Soloway MS, Manoharan M, Ayyathurai R, Samavedi S (2008) Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy. J Urol 179: 91\u201395; discussion 95","journal-title":"J Urol"},{"key":"BF6605325_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M","volume":"86","author":"P Brennan","year":"2000","unstructured":"Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jockel KH, Donato F, Serra C, Wahrendorf J, Hours M, T\u2019Mannetje A, Kogevinas M, Boffetta P (2000) Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 86: 289\u2013294","journal-title":"Int J Cancer"},{"key":"BF6605325_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1023\/A:1011214222810","volume":"12","author":"P Brennan","year":"2001","unstructured":"Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, Jockel KH, Lopez-Abente G, Tzonou A, Vineis P, Donato F, Hours M, Serra C, Bolm-Audorff U, Schill W, Kogevinas M, Boffetta P (2001) The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 12: 411\u2013417","journal-title":"Cancer Causes Control"},{"key":"BF6605325_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bjc.6602654","volume":"93","author":"P Brennan","year":"2005","unstructured":"Brennan P, Scelo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Seow A, Pompe-Kirn V, Martos C, Jonasson JG, Colin D, Boffetta P (2005) Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 93: 159\u2013166","journal-title":"Br J Cancer"},{"key":"BF6605325_CR10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1158\/1055-9965.EPI-05-0899","volume":"15","author":"C Chao","year":"2006","unstructured":"Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M (2006) NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 979\u2013987","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6605325_CR11","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/jnci\/djm201","volume":"99","author":"AK Chaturvedi","year":"2007","unstructured":"Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB (2007) Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 99: 1634\u20131643","journal-title":"J Natl Cancer Inst"},{"key":"BF6605325_CR12","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1158\/1055-9965.EPI-07-2876","volume":"17","author":"SC Chuang","year":"2008","unstructured":"Chuang SC, Hashibe M, Scelo G, Brewster DH, Pukkala E, Friis S, Tracey E, Weiderpass E, Hemminki K, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Dresler CM, Boffetta P, Brennan P (2008) Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev 17: 1543\u20131549","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6605325_CR13","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","volume":"20","author":"GM Dores","year":"2002","unstructured":"Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, van\u2019t Veer MB, Stovall M, Gospodarowicz M, Travis LB (2002) Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 20: 3484\u20133494","journal-title":"J Clin Oncol"},{"key":"BF6605325_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/nature05887","volume":"447","author":"DF Easton","year":"2007","unstructured":"Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schurmann P, Dork T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087\u20131093","journal-title":"Nature"},{"key":"BF6605325_CR15","unstructured":"Engholm G, Storm HH, Ferlay J, Christensen N, Bray F, Olafsdottir E, Pukkala E, Talb\u00e4ck M (2007) Software reference NORDCAN: Cancer Incidence And Mortality In The Nordic Countries, Version 3.0. Association of Nordic Cancer Registries. Danish Cancer Society"},{"key":"BF6605325_CR16","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/carcin\/bgm132","volume":"28","author":"JD Figueroa","year":"2007","unstructured":"Figueroa JD, Malats N, Rothman N, Real FX, Silverman D, Kogevinas M, Chanock S, Yeager M, Welch R, Dosemeci M, Tardon A, Serra C, Carrato A, Garcia-Closas R, Castano-Vinyals G, Garcia-Closas M (2007) Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis 28: 1788\u20131793","journal-title":"Carcinogenesis"},{"key":"BF6605325_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/gyno.1996.4551","volume":"64","author":"G Fisher","year":"1997","unstructured":"Fisher G, Harlow SD, Schottenfeld D (1997) Cumulative risk of second primary cancers in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985\u20131992. Gynecol Oncol 64: 213\u2013223","journal-title":"Gynecol Oncol"},{"key":"BF6605325_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ijc.23033","volume":"122","author":"S Gandini","year":"2008","unstructured":"Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, Boyle P (2008) Tobacco smoking and cancer: a meta-analysis. Int J Cancer 122: 155\u2013164","journal-title":"Int J Cancer"},{"key":"BF6605325_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jama.293.7.810","volume":"293","author":"HB Grossman","year":"2005","unstructured":"Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, Shen Y (2005) Detection of bladder cancer using a point-of-care proteomic assay. JAMA 293: 810\u2013816","journal-title":"JAMA"},{"key":"BF6605325_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10552-004-8023-0","volume":"16","author":"A Heard","year":"2005","unstructured":"Heard A, Roder D, Luke C (2005) Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia). Cancer Causes Control 16: 475\u2013481","journal-title":"Cancer Causes Control"},{"issue":"2","key":"BF6605325_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/ijc.23856","volume":"124","author":"M Hemelt","year":"2008","unstructured":"Hemelt M, Yamamoto H, Cheng KK, Zeegers MP (2008) The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer 124 (2): 412\u2013419","journal-title":"Int J Cancer"},{"key":"BF6605325_CR22","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1200\/JCO.2007.14.6068","volume":"26","author":"K Hemminki","year":"2008","unstructured":"Hemminki K, Lenner P, Sundquist J, Bermejo JL (2008) Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis. J Clin Oncol 26: 1850\u20131857","journal-title":"J Clin Oncol"},{"key":"BF6605325_CR23","unstructured":"IARC (2004) Tobacco Smoke And Involuntary Smoking Vol. 83. World Health Organisation. International Agency for Research on Cancer: Lyon, France"},{"key":"BF6605325_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ijc.2910390506","volume":"39","author":"JM Kaldor","year":"1987","unstructured":"Kaldor JM, Day NE, Band P, Choi NW, Clarke EA, Coleman MP, Hakama M, Koch M, Langmark F, Neal FE, Pettersson F, Pompe-Kim V, Prior P, Storm HH (1987) Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 39: 571\u2013585","journal-title":"Int J Cancer"},{"key":"BF6605325_CR25","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.ejca.2007.04.011","volume":"43","author":"E Kellen","year":"2007","unstructured":"Kellen E, Zeegers MP, Dirx M, Houterman S, Droste J, Lawrence G, Truyers C, Bruckers L, Molenberghs G, Joniau S, Buntinx F (2007) Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom. Eur J Cancer 43: 1694\u20131700","journal-title":"Eur J Cancer"},{"key":"BF6605325_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/ng.229","volume":"40","author":"LA Kiemeney","year":"2008","unstructured":"Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN, Gudmundsson J, Jakobsdottir M, Bergthorsson JT, Sigurdsson A, Blondal T, Witjes JA, Vermeulen SH, Hulsbergen-van de Kaa CA, Swinkels DW, Ploeg M, Cornel EB, Vergunst H, Thorgeirsson TE, Gudbjartsson D, Gudjonsson SA, Thorleifsson G, Kristinsson KT, Mouy M, Snorradottir S, Placidi D, Campagna M, Arici C, Koppova K, Gurzau E, Rudnai P, Kellen E, Polidoro S, Guarrera S, Sacerdote C, Sanchez M, Saez B, Valdivia G, Ryk C, de Verdier P, Lindblom A, Golka K, Bishop DT, Knowles MA, Nikulasson S, Petursdottir V, Jonsson E, Geirsson G, Kristjansson B, Mayordomo JI, Steineck G, Porru S, Buntinx F, Zeegers MP, Fletcher T, Kumar R, Matullo G, Vineis P, Kiltie AE, Gulcher JR, Thorsteinsdottir U, Kong A, Rafnar T, Stefansson K (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 40: 1307\u20131312","journal-title":"Nat Genet"},{"key":"BF6605325_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2004.08.020","volume":"217","author":"G La Torre","year":"2005","unstructured":"La Torre G, Boccia S, Ricciardi G (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217: 53\u201360","journal-title":"Cancer Lett"},{"key":"BF6605325_CR28","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/ijc.22414","volume":"120","author":"O Landgren","year":"2007","unstructured":"Landgren O, Pfeiffer RM, Stewart L, Gridley G, Mellemkjaer L, Hemminki K, Goldin LR, Travis LB (2007) Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer 120: 1099\u20131102","journal-title":"Int J Cancer"},{"key":"BF6605325_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/bjc.1996.538","volume":"74","author":"F Levi","year":"1996","unstructured":"Levi F, Randimbison L, La Vecchia C, Franceschi S (1996) Incidence of invasive cancers following carcinoma in situ of the cervix. Br J Cancer 74: 1321\u20131323","journal-title":"Br J Cancer"},{"key":"BF6605325_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<186::AID-CNCR25>3.0.CO;2-3","volume":"86","author":"F Levi","year":"1999","unstructured":"Levi F, Randimbison L, Te VC, La Vecchia C (1999) Second primary cancers in patients with lung carcinoma. Cancer 86: 186\u2013190","journal-title":"Cancer"},{"key":"BF6605325_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ijrobp.2006.05.016","volume":"66","author":"SL Liauw","year":"2006","unstructured":"Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD (2006) Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66: 669\u2013673","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF6605325_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00066-007-1786-y","volume":"183","author":"AC Muller","year":"2007","unstructured":"Muller AC, Ganswindt U, Bamberg M, Belka C (2007) Risk of second malignancies after prostate irradiation? Strahlenther Onkol 183: 605\u2013609","journal-title":"Strahlenther Onkol"},{"key":"BF6605325_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00345-007-0168-5","volume":"25","author":"C Murta-Nascimento","year":"2007","unstructured":"Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, Malats N (2007a) Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 25: 285\u2013295","journal-title":"World J Urol"},{"key":"BF6605325_CR34","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1158\/1055-9965.EPI-06-0743","volume":"16","author":"C Murta-Nascimento","year":"2007","unstructured":"Murta-Nascimento C, Silverman DT, Kogevinas M, Garcia-Closas M, Rothman N, Tardon A, Garcia-Closas R, Serra C, Carrato A, Villanueva C, Dosemeci M, Real FX, Malats N (2007b) Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 16: 1595\u20131600","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6605325_CR35","unstructured":"National Board of Health and Welfare, Sweden (2007) Cancer Incidence in Sweden, 2006"},{"key":"BF6605325_CR36","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<625::AID-IJC2>3.0.CO;2-Z","volume":"73","author":"LA Nordlund","year":"1997","unstructured":"Nordlund LA, Carstensen JM, Pershagen G (1997) Cancer incidence in female smokers: a 26-year follow-up. Int J Cancer 73: 625\u2013628","journal-title":"Int J Cancer"},{"key":"BF6605325_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/10428199209051035","volume":"8","author":"AB Pathak","year":"1992","unstructured":"Pathak AB, Advani SH, Gopal R, Nadkarni KS, Saikia TK (1992) Urinary bladder cancer following cyclophosphamide therapy for Hodgkin's disease. Leuk Lymphoma 8: 503\u2013504","journal-title":"Leuk Lymphoma"},{"key":"BF6605325_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/00016349009006163","volume":"69","author":"F Pettersson","year":"1990","unstructured":"Pettersson F, Ryberg M, Malker B (1990) Second primary cancer after treatment of invasive carcinoma of the uterine cervix, compared with those arising after treatment for in situ carcinomas. An effect of irradiation? A cancer registry study. Acta Obstet Gynecol Scand 69: 161\u2013174","journal-title":"Acta Obstet Gynecol Scand"},{"key":"BF6605325_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3816\/CLC.2008.n.016","volume":"9","author":"KE Rusthoven","year":"2008","unstructured":"Rusthoven KE, Flaig TW, Raben D, Kavanagh BD (2008) High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials. Clin Lung Cancer 9: 106\u2013111","journal-title":"Clin Lung Cancer"},{"key":"BF6605325_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1349-7006.2006.00207.x","volume":"97","author":"M Saadat","year":"2006","unstructured":"Saadat M (2006) Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 97: 505\u2013509","journal-title":"Cancer Sci"},{"key":"BF6605325_CR41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/aje\/kwm167","volume":"166","author":"S Sanderson","year":"2007","unstructured":"Sanderson S, Salanti G, Higgins J (2007) Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis. Am J Epidemiol 166: 741\u2013751","journal-title":"Am J Epidemiol"},{"key":"BF6605325_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/bmj.3.5768.248-b","volume":"3","author":"JM Simister","year":"1971","unstructured":"Simister JM (1971) Cyclophosphamide and the bladder. Br Med J 3: 248\u2013249","journal-title":"Br Med J"},{"key":"BF6605325_CR43","first-page":"S2","volume":"179","author":"A Singh","year":"2008","unstructured":"Singh A, Kinoshita Y, Rovito Jr PM, Landas S, Silberstein J, Nsouli I, Wang CY, Haas GP (2008) Higher than expected association of clinical prostate and bladder cancers. J Urol 179: S2\u2013S5","journal-title":"J Urol"},{"key":"BF6605325_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/14034940510032301","volume":"33","author":"B Stegmayr","year":"2005","unstructured":"Stegmayr B, Eliasson M, Rodu B (2005) The decline of smoking in northern Sweden. Scand J Public Health 33: 321\u2013324; discussion 243","journal-title":"Scand J Public Health"},{"key":"BF6605325_CR45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0959-8049(00)00428-7","volume":"37","author":"L Teppo","year":"2001","unstructured":"Teppo L, Salminen E, Pukkala E (2001) Risk of a new primary cancer among patients with lung cancer of different histological types. Eur J Cancer 37: 613\u2013619","journal-title":"Eur J Cancer"},{"key":"BF6605325_CR46","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/jnci\/87.7.524","volume":"87","author":"LB Travis","year":"1995","unstructured":"Travis LB, Curtis RE, Glimelius B, Holowaty EJ, Van Leeuwen FE, Lynch CF, Hagenbeek A, Stovall M, Banks PM, Adami J, Gospodarowicz MK, Wacholder S, Inskip PD, Tucker MA, Boice JD (1995) Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 87: 524\u2013530","journal-title":"J Natl Cancer Inst"},{"key":"BF6605325_CR47","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/jnci\/89.19.1429","volume":"89","author":"LB Travis","year":"1997","unstructured":"Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, Van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Andersson M, Bergfeldt K, Clarke EA, Wiklund T, Stoter G, Gospodarowicz M, Sturgeon J, Fraumeni Jr JF, Boice Jr JD (1997) Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 89: 1429\u20131439","journal-title":"J Natl Cancer Inst"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605325","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:42:03Z","timestamp":1684413723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,15]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BF6605325"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605325","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,15]]}}}